Lewis; Timothy

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lewis; Timothy.The latest application filed is for "compounds and methods for the treatment of malaria".

Company Profile

9.12.14

Lewis; Timothy - Kenmore WA
Lewis; Timothy - Cambridge MA
Lewis; Timothy - Rowlette TX
LEWIS; Timothy - Bothell WA
Lewis; Timothy - Marlborough MA
Lewis; Timothy - El Dorado Hills CA
Lewis; Timothy - Framingham MA
Lewis; Timothy - Fremont CA
Lewis; Timothy - Hilton NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Anti-NTB-A antibodies and related compositions and methods Grant 11,351,269 - Lewis , et al. June 7, 2	2022-06-07
Compounds and methods for the treatment of malaria Grant 11,325,913 - Comer , et al. May 10, 2	2022-05-10
Compounds And Methods For The Treatment Of Malaria App 20200399276 - COMER; EAMON ; et al.	2020-12-24
Individual nystagmus simulated training experience Grant 10,839,713 - Zielke , et al. November 17, 2	2020-11-17
Cd48 Antibodies And Conjugates Thereof App 20200289661 - Lewis; Timothy ; et al.	2020-09-17
Compounds and methods for the treatment of malaria Grant 10,738,055 - Comer , et al. A	2020-08-11
Anti-cd228 Antibodies And Antibody-drug Conjugates App 20200246479 - Kind Code	2020-08-06
6-phenyl-4,5-dihydropyridazin-3(2h)-one Derivatives As Pde3a And Pde3b Inhibitors For Treating Cancer App 20200247783 - Kind Code	2020-08-06
CD48 antibodies and conjugates thereof Grant 10,722,592 - Lewis , et al.	2020-07-28
Compounds And Methods For The Treatment Of Malaria App 20190055252 - COMER; EAMON ; et al.	2019-02-21
Direct inhibitors of Keap1-Nrf2 interaction as antioxidant inflammation modulators Grant 10,106,502 - Hu , et al. October 23, 2	2018-10-23
Compounds and methods for the treatment of malaria Grant 10,059,711 - Comer , et al. August 28, 2	2018-08-28
Anti-ntb-a Antibodies And Related Compositions And Methods App 20180169257 - Lewis; Timothy ; et al.	2018-06-21
Direct Inhibitors Of Keap1-nrf2 Interaction As Antioxidant Inflammation Modulators App 20180148408 - Hu; Longqin ; et al.	2018-05-31
Cd48 Antibodies And Conjugates Thereof App 20180092984 - Lewis; Timothy ; et al.	2018-04-05
Individual Nystagmus Simulated Training Experience App 20170372633 - Zielke; Marjorie A. ; et al.	2017-12-28
Compounds And Methods For The Treatment Of Malaria App 20160289235 - COMER; EAMON ; et al.	2016-10-06
Direct Inhibitors Of Keap1-nrf2 Interaction As Antioxidant Inflammation Modulators App 20140256767 - Hu; Longqin ; et al.	2014-09-11
Bluetooth Pre-boot Authentication In Bios App 20100299510 - Ueltschey; Chip ; et al.	2010-11-25
Compounds and methods for treatment of asthma, allergy and inflammatory disorders Grant 6,894,059 - Scannell , et al. May 17, 2	2005-05-17
Compounds and methods for treatment of asthma, allergy and inflammatory disorders Grant 6,797,713 - Scannell , et al. September 28, 2	2004-09-28
Compounds and methods for treatment of asthma, allergy and inflammatory disorders App 20040048875 - Scannell, Ralph ; et al.	2004-03-11
Compounds and methods for treatment of asthma, allergy and inflammatory disorders Grant 6,686,502 - Cai , et al. February 3, 2	2004-02-03
Compounds and methods for treatment of asthma, allergy and inflammatory disorders App 20030220347 - Scannell, Ralph ; et al.	2003-11-27
Data transfer to a non-volatile storage medium Grant 6,145,068 - Lewis November 7, 2	2000-11-07
Sheet media handling apparatus Grant 5,379,999 - Barzideh , et al. January 10, 1	1995-01-10

Company Registrations

NCAGE Code	5C4S0	LEWIS TIMOTHY!DBA LEWIS ENGINEERING GROUP
CAGE Code	5C4S0	LEWIS, TIMOTHY LEWIS ENGINEERING GROUP

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.